Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
A: According to medical guidance: Life-Threatening Symptoms (Call 911): Difficulty breathing or severe shortness of breath Swelling of face, lips, tongue, or throat Severe allergic reaction (anaphylaxis) Chest pain Severe abdominal pain not resolving Loss of consciousness Serious but Non-Emergency Symptoms (Contact Provider Immediately/Same Day): Severe persistent nausea or vomiting (risk of dehydration) Inability to keep down fluids Severe abdominal pain Yellowing of skin or eyes (jaundice) Decreased or no urination Vision changes Lump or swelling in neck New or worsening depression or suicidal thoughts Moderate Bothersome Symptoms (Contact Provider Within 24-48 Hours): Nausea interfering with daily activities Persistent diarrhea or constipation Significant injection site reactions Concerning hair loss Other symptoms significantly impacting quality of life Response Options : Provider may adjust dose (slower escalation or temporary reduction) Provider may prescribe additional medications for symptom management Provider may recommend medication switch In rare cases, may recommend discontinuation Never hesitate to contact provider about concerning symptoms
Om dina personuppgifter behandlas utanfr EES sker detta endast i lnder fr vilka Europeiska kommissionen har beslutat att de skerstller en adekvat skyddsniv, eller dr lmpliga skyddstgrder finns p plats
Tirzepatide has an elimination half-life of approximately five days, so the amount present in the body decreases gradually after the last dose
10.1111/j.0031-9317.2004.0203.x 80 RouhierN.GelhayeE.JacquotJ
Lopes, N
Case report: anorgasmia following initiation of GLP-1 agonist
US$ 20.64
US$ 20.90
US$ 22.27
US$ 23.20
